Babesia Microti, Borrelia Burgdorferi Nosode

FDA Drug Profile — BOBA HOMO

Babesia Microti, Borrelia Burgdorferi Nosode is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including BOBA HOMO. Available dosage form: liquid.

Drug Details

Generic Name
Babesia Microti, Borrelia Burgdorferi Nosode
Brand Names
BOBA HOMO
Application Number
Sponsor
Deseret Biologicals, Inc.
NDC Codes
1
Dosage Forms
LIQUID
Routes
ORAL
Active Ingredients
BABESIA MICROTI, BORRELIA BURGDORFERI

Indications and Usage

INDICATIONS: Supports the immune system for host resistance to Lyme disease and co-infections.

Warnings

WARNINGS: If pregnant or nursing ask your health Care Practitioner before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry and dark place.